Loading…

Titanium Tackles the Endoplasmic Reticulum: A First Genomic Study on a Titanium Anticancer Metallodrug

PhenolaTi is an advanced non-toxic anticancer chemotherapy; this inert bis(phenolato)bis(alkoxo) Ti(IV) complex demonstrates the intriguing combination of high and wide efficacy with no detected toxicity in animals. Here we unravel the cellular pathways involved in its mechanism of action by a first...

Full description

Saved in:
Bibliographic Details
Published in:iScience 2020-07, Vol.23 (7), p.101262, Article 101262
Main Authors: Miller, Maya, Mellul, Anna, Braun, Maya, Sherill-Rofe, Dana, Cohen, Emiliano, Shpilt, Zohar, Unterman, Irene, Braitbard, Ori, Hochman, Jacob, Tshuva, Edit Y., Tabach, Yuval
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c521t-b48aef5f39d4919a1d5133fff8f417ab798c2b9a5cdd7779e9ad6a779936ad293
cites cdi_FETCH-LOGICAL-c521t-b48aef5f39d4919a1d5133fff8f417ab798c2b9a5cdd7779e9ad6a779936ad293
container_end_page
container_issue 7
container_start_page 101262
container_title iScience
container_volume 23
creator Miller, Maya
Mellul, Anna
Braun, Maya
Sherill-Rofe, Dana
Cohen, Emiliano
Shpilt, Zohar
Unterman, Irene
Braitbard, Ori
Hochman, Jacob
Tshuva, Edit Y.
Tabach, Yuval
description PhenolaTi is an advanced non-toxic anticancer chemotherapy; this inert bis(phenolato)bis(alkoxo) Ti(IV) complex demonstrates the intriguing combination of high and wide efficacy with no detected toxicity in animals. Here we unravel the cellular pathways involved in its mechanism of action by a first genome study on Ti(IV)-treated cells, using an attuned RNA sequencing-based available technology. First, phenolaTi induced apoptosis and cell-cycle arrest at the G2/M phase in MCF7 cells. Second, the transcriptome of the treated cells was analyzed, identifying alterations in pathways relating to protein translation, DNA damage, and mitochondrial eruption. Unlike for common metallodrugs, electrophoresis assay showed no inhibition of DNA polymerase activity. Reduced in vitro cytotoxicity with added endoplasmic reticulum (ER) stress inhibitor supported the ER as a putative cellular target. Altogether, this paper reveals a distinct ER-related mechanism by the Ti(IV) anticancer coordination complex, paving the way for wider applicability of related techniques in mechanistic analyses of metallodrugs. [Display omitted] •First in-depth mechanistic analysis of a non-toxic Ti-based anticancer metallodrug•A comprehensive RNA-seq analysis to map the transcriptomic netowrk initiated by phenolaTi.•Unraveling a distinct mechanism through ER stress, not through direct DNA binding•Toward understanding and applicability of diverse better-tolerable chemotherapies Organometallic Chemistry; Biochemistry; Genomics; Cancer
doi_str_mv 10.1016/j.isci.2020.101262
format article
fullrecord <record><control><sourceid>pubmed_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_1e1aa86012944e248f2c9a8a4d91867f</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S258900422030448X</els_id><doaj_id>oai_doaj_org_article_1e1aa86012944e248f2c9a8a4d91867f</doaj_id><sourcerecordid>32585595</sourcerecordid><originalsourceid>FETCH-LOGICAL-c521t-b48aef5f39d4919a1d5133fff8f417ab798c2b9a5cdd7779e9ad6a779936ad293</originalsourceid><addsrcrecordid>eNp9kd1qGzEQhUVpaEKaF-hF0QvYlbTaH5VSMCFJAymF1L0WY2nkyN1dGUkbyNtXzrYmuemVhjlnPklzCPnA2ZIz3nzaLX0yfimYeG6IRrwhZ6Lu1IIxKd6-qE_JRUo7xoqTCamad-S0KmJdq_qMuLXPMPppoGswv3tMND8gvRpt2PeQBm_oPWZvpn4aPtMVvfYxZXqDYzhIP_Nkn2gYKdAjZjUWO4wGI_2OGfo-2Dht35MTB33Ci7_nOfl1fbW-_La4-3Fze7m6W5ha8LzYyA7Q1a5SViqugNuaV5VzrnOSt7BpVWfERkFtrG3bVqEC20ApVNWAFao6J7cz1wbY6X30A8QnHcDr50aIWw2xPLBHzZEDdE1ZnZISheycMAo6kFbxrmldYX2dWftpM6A1OOYI_Svoa2X0D3obHnVbCcFaWQBiBpgYUorojrOc6UOIeqcPIepDiHoOsQx9fHnrceRfZMXwZTZg2eOjx6gLAsvCrY9ocvmo_x__D5Asrv4</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Titanium Tackles the Endoplasmic Reticulum: A First Genomic Study on a Titanium Anticancer Metallodrug</title><source>ScienceDirect (Online service)</source><source>PubMed Central</source><creator>Miller, Maya ; Mellul, Anna ; Braun, Maya ; Sherill-Rofe, Dana ; Cohen, Emiliano ; Shpilt, Zohar ; Unterman, Irene ; Braitbard, Ori ; Hochman, Jacob ; Tshuva, Edit Y. ; Tabach, Yuval</creator><creatorcontrib>Miller, Maya ; Mellul, Anna ; Braun, Maya ; Sherill-Rofe, Dana ; Cohen, Emiliano ; Shpilt, Zohar ; Unterman, Irene ; Braitbard, Ori ; Hochman, Jacob ; Tshuva, Edit Y. ; Tabach, Yuval</creatorcontrib><description>PhenolaTi is an advanced non-toxic anticancer chemotherapy; this inert bis(phenolato)bis(alkoxo) Ti(IV) complex demonstrates the intriguing combination of high and wide efficacy with no detected toxicity in animals. Here we unravel the cellular pathways involved in its mechanism of action by a first genome study on Ti(IV)-treated cells, using an attuned RNA sequencing-based available technology. First, phenolaTi induced apoptosis and cell-cycle arrest at the G2/M phase in MCF7 cells. Second, the transcriptome of the treated cells was analyzed, identifying alterations in pathways relating to protein translation, DNA damage, and mitochondrial eruption. Unlike for common metallodrugs, electrophoresis assay showed no inhibition of DNA polymerase activity. Reduced in vitro cytotoxicity with added endoplasmic reticulum (ER) stress inhibitor supported the ER as a putative cellular target. Altogether, this paper reveals a distinct ER-related mechanism by the Ti(IV) anticancer coordination complex, paving the way for wider applicability of related techniques in mechanistic analyses of metallodrugs. [Display omitted] •First in-depth mechanistic analysis of a non-toxic Ti-based anticancer metallodrug•A comprehensive RNA-seq analysis to map the transcriptomic netowrk initiated by phenolaTi.•Unraveling a distinct mechanism through ER stress, not through direct DNA binding•Toward understanding and applicability of diverse better-tolerable chemotherapies Organometallic Chemistry; Biochemistry; Genomics; Cancer</description><identifier>ISSN: 2589-0042</identifier><identifier>EISSN: 2589-0042</identifier><identifier>DOI: 10.1016/j.isci.2020.101262</identifier><identifier>PMID: 32585595</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Biochemistry ; Cancer ; Genomics ; Organometallic Chemistry</subject><ispartof>iScience, 2020-07, Vol.23 (7), p.101262, Article 101262</ispartof><rights>2020 The Authors</rights><rights>Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.</rights><rights>2020 The Authors 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c521t-b48aef5f39d4919a1d5133fff8f417ab798c2b9a5cdd7779e9ad6a779936ad293</citedby><cites>FETCH-LOGICAL-c521t-b48aef5f39d4919a1d5133fff8f417ab798c2b9a5cdd7779e9ad6a779936ad293</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7322074/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S258900422030448X$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,3549,27924,27925,45780,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32585595$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Miller, Maya</creatorcontrib><creatorcontrib>Mellul, Anna</creatorcontrib><creatorcontrib>Braun, Maya</creatorcontrib><creatorcontrib>Sherill-Rofe, Dana</creatorcontrib><creatorcontrib>Cohen, Emiliano</creatorcontrib><creatorcontrib>Shpilt, Zohar</creatorcontrib><creatorcontrib>Unterman, Irene</creatorcontrib><creatorcontrib>Braitbard, Ori</creatorcontrib><creatorcontrib>Hochman, Jacob</creatorcontrib><creatorcontrib>Tshuva, Edit Y.</creatorcontrib><creatorcontrib>Tabach, Yuval</creatorcontrib><title>Titanium Tackles the Endoplasmic Reticulum: A First Genomic Study on a Titanium Anticancer Metallodrug</title><title>iScience</title><addtitle>iScience</addtitle><description>PhenolaTi is an advanced non-toxic anticancer chemotherapy; this inert bis(phenolato)bis(alkoxo) Ti(IV) complex demonstrates the intriguing combination of high and wide efficacy with no detected toxicity in animals. Here we unravel the cellular pathways involved in its mechanism of action by a first genome study on Ti(IV)-treated cells, using an attuned RNA sequencing-based available technology. First, phenolaTi induced apoptosis and cell-cycle arrest at the G2/M phase in MCF7 cells. Second, the transcriptome of the treated cells was analyzed, identifying alterations in pathways relating to protein translation, DNA damage, and mitochondrial eruption. Unlike for common metallodrugs, electrophoresis assay showed no inhibition of DNA polymerase activity. Reduced in vitro cytotoxicity with added endoplasmic reticulum (ER) stress inhibitor supported the ER as a putative cellular target. Altogether, this paper reveals a distinct ER-related mechanism by the Ti(IV) anticancer coordination complex, paving the way for wider applicability of related techniques in mechanistic analyses of metallodrugs. [Display omitted] •First in-depth mechanistic analysis of a non-toxic Ti-based anticancer metallodrug•A comprehensive RNA-seq analysis to map the transcriptomic netowrk initiated by phenolaTi.•Unraveling a distinct mechanism through ER stress, not through direct DNA binding•Toward understanding and applicability of diverse better-tolerable chemotherapies Organometallic Chemistry; Biochemistry; Genomics; Cancer</description><subject>Biochemistry</subject><subject>Cancer</subject><subject>Genomics</subject><subject>Organometallic Chemistry</subject><issn>2589-0042</issn><issn>2589-0042</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp9kd1qGzEQhUVpaEKaF-hF0QvYlbTaH5VSMCFJAymF1L0WY2nkyN1dGUkbyNtXzrYmuemVhjlnPklzCPnA2ZIz3nzaLX0yfimYeG6IRrwhZ6Lu1IIxKd6-qE_JRUo7xoqTCamad-S0KmJdq_qMuLXPMPppoGswv3tMND8gvRpt2PeQBm_oPWZvpn4aPtMVvfYxZXqDYzhIP_Nkn2gYKdAjZjUWO4wGI_2OGfo-2Dht35MTB33Ci7_nOfl1fbW-_La4-3Fze7m6W5ha8LzYyA7Q1a5SViqugNuaV5VzrnOSt7BpVWfERkFtrG3bVqEC20ApVNWAFao6J7cz1wbY6X30A8QnHcDr50aIWw2xPLBHzZEDdE1ZnZISheycMAo6kFbxrmldYX2dWftpM6A1OOYI_Svoa2X0D3obHnVbCcFaWQBiBpgYUorojrOc6UOIeqcPIepDiHoOsQx9fHnrceRfZMXwZTZg2eOjx6gLAsvCrY9ocvmo_x__D5Asrv4</recordid><startdate>20200724</startdate><enddate>20200724</enddate><creator>Miller, Maya</creator><creator>Mellul, Anna</creator><creator>Braun, Maya</creator><creator>Sherill-Rofe, Dana</creator><creator>Cohen, Emiliano</creator><creator>Shpilt, Zohar</creator><creator>Unterman, Irene</creator><creator>Braitbard, Ori</creator><creator>Hochman, Jacob</creator><creator>Tshuva, Edit Y.</creator><creator>Tabach, Yuval</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20200724</creationdate><title>Titanium Tackles the Endoplasmic Reticulum: A First Genomic Study on a Titanium Anticancer Metallodrug</title><author>Miller, Maya ; Mellul, Anna ; Braun, Maya ; Sherill-Rofe, Dana ; Cohen, Emiliano ; Shpilt, Zohar ; Unterman, Irene ; Braitbard, Ori ; Hochman, Jacob ; Tshuva, Edit Y. ; Tabach, Yuval</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c521t-b48aef5f39d4919a1d5133fff8f417ab798c2b9a5cdd7779e9ad6a779936ad293</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Biochemistry</topic><topic>Cancer</topic><topic>Genomics</topic><topic>Organometallic Chemistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Miller, Maya</creatorcontrib><creatorcontrib>Mellul, Anna</creatorcontrib><creatorcontrib>Braun, Maya</creatorcontrib><creatorcontrib>Sherill-Rofe, Dana</creatorcontrib><creatorcontrib>Cohen, Emiliano</creatorcontrib><creatorcontrib>Shpilt, Zohar</creatorcontrib><creatorcontrib>Unterman, Irene</creatorcontrib><creatorcontrib>Braitbard, Ori</creatorcontrib><creatorcontrib>Hochman, Jacob</creatorcontrib><creatorcontrib>Tshuva, Edit Y.</creatorcontrib><creatorcontrib>Tabach, Yuval</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>iScience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Miller, Maya</au><au>Mellul, Anna</au><au>Braun, Maya</au><au>Sherill-Rofe, Dana</au><au>Cohen, Emiliano</au><au>Shpilt, Zohar</au><au>Unterman, Irene</au><au>Braitbard, Ori</au><au>Hochman, Jacob</au><au>Tshuva, Edit Y.</au><au>Tabach, Yuval</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Titanium Tackles the Endoplasmic Reticulum: A First Genomic Study on a Titanium Anticancer Metallodrug</atitle><jtitle>iScience</jtitle><addtitle>iScience</addtitle><date>2020-07-24</date><risdate>2020</risdate><volume>23</volume><issue>7</issue><spage>101262</spage><pages>101262-</pages><artnum>101262</artnum><issn>2589-0042</issn><eissn>2589-0042</eissn><abstract>PhenolaTi is an advanced non-toxic anticancer chemotherapy; this inert bis(phenolato)bis(alkoxo) Ti(IV) complex demonstrates the intriguing combination of high and wide efficacy with no detected toxicity in animals. Here we unravel the cellular pathways involved in its mechanism of action by a first genome study on Ti(IV)-treated cells, using an attuned RNA sequencing-based available technology. First, phenolaTi induced apoptosis and cell-cycle arrest at the G2/M phase in MCF7 cells. Second, the transcriptome of the treated cells was analyzed, identifying alterations in pathways relating to protein translation, DNA damage, and mitochondrial eruption. Unlike for common metallodrugs, electrophoresis assay showed no inhibition of DNA polymerase activity. Reduced in vitro cytotoxicity with added endoplasmic reticulum (ER) stress inhibitor supported the ER as a putative cellular target. Altogether, this paper reveals a distinct ER-related mechanism by the Ti(IV) anticancer coordination complex, paving the way for wider applicability of related techniques in mechanistic analyses of metallodrugs. [Display omitted] •First in-depth mechanistic analysis of a non-toxic Ti-based anticancer metallodrug•A comprehensive RNA-seq analysis to map the transcriptomic netowrk initiated by phenolaTi.•Unraveling a distinct mechanism through ER stress, not through direct DNA binding•Toward understanding and applicability of diverse better-tolerable chemotherapies Organometallic Chemistry; Biochemistry; Genomics; Cancer</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>32585595</pmid><doi>10.1016/j.isci.2020.101262</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2589-0042
ispartof iScience, 2020-07, Vol.23 (7), p.101262, Article 101262
issn 2589-0042
2589-0042
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_1e1aa86012944e248f2c9a8a4d91867f
source ScienceDirect (Online service); PubMed Central
subjects Biochemistry
Cancer
Genomics
Organometallic Chemistry
title Titanium Tackles the Endoplasmic Reticulum: A First Genomic Study on a Titanium Anticancer Metallodrug
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T17%3A39%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Titanium%20Tackles%20the%20Endoplasmic%20Reticulum:%20A%20First%20Genomic%20Study%20on%20a%20Titanium%20Anticancer%20Metallodrug&rft.jtitle=iScience&rft.au=Miller,%20Maya&rft.date=2020-07-24&rft.volume=23&rft.issue=7&rft.spage=101262&rft.pages=101262-&rft.artnum=101262&rft.issn=2589-0042&rft.eissn=2589-0042&rft_id=info:doi/10.1016/j.isci.2020.101262&rft_dat=%3Cpubmed_doaj_%3E32585595%3C/pubmed_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c521t-b48aef5f39d4919a1d5133fff8f417ab798c2b9a5cdd7779e9ad6a779936ad293%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/32585595&rfr_iscdi=true